# A Second-generation AI Based Therapeutic Regimen in Patients With Gaucher Disease Treated With Enzyme Replacement Therapy.

> **NCT06050967** · PHASE2 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 5 (actual)

## Conditions studied

- Gaucher Disease Type 1

## Interventions

- **COMBINATION_PRODUCT:** Enzyme replacement therapy for Gaucher disease in combination with altus care application

## Key facts

- **NCT ID:** NCT06050967
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06050967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06050967, "A Second-generation AI Based Therapeutic Regimen in Patients With Gaucher Disease Treated With Enzyme Replacement Therapy.". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06050967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*